💉 Pralidoxime Chloride (2-PAM) Injection 25 mg/mL
📌 Description:
Pralidoxime Chloride (2-PAM) is an antidote used to reverse the effects of organophosphate pesticide or nerve agent poisoning. It works by reactivating cholinesterase enzymes that are inhibited by these toxic compounds, thus restoring normal nerve function.
📜 Prescription:
- Schedule: Prescription-only medication.
- Administration: IM (intramuscular) or IV (intravenous) injection.
- Commonly Co-administered With: Atropine (for synergistic action in poisoning cases).
🌿 Nature:
- Type: Antidote.
- Class: Cholinesterase reactivator.
- Form: Injectable solution.
- Concentration: 25 mg/mL.
✅ Advantages:
- Reverses life-threatening neuromuscular symptoms of poisoning.
- Reduces the risk of respiratory failure caused by nerve agent exposure.
- Effective adjunct to atropine in organophosphate poisoning.
- Can be life-saving when used promptly in emergencies.
⚠️ Precautions:
- Use with caution in:
- Renal impairment – drug is renally excreted.
- Myasthenia gravis – may worsen symptoms.
- Pregnancy/lactation – only if clearly needed.
- May cause:
- Dizziness, blurred vision, headache.
- Tachycardia, muscle rigidity, or weakness.
- Local injection site reactions.
- Monitor respiratory status, renal function, and blood pressure during administration.
🧊 Storage:
- Store below 25°C (77°F).
- Protect from light.
- Keep out of reach of children.
- Do not freeze.
📦 Common Packaging:
- Ampoules or vials: 1 mL, 5 mL, or 10 mL (typically 25 mg/mL concentration).
- Supplied in emergency antidote kits alongside atropine.
👩⚕️ Patient Advice
- This injection is for emergency use only by trained healthcare professionals.
- It is used to reverse poisoning caused by certain pesticides or nerve agents.
- You may feel dizzy or weak after receiving the injection—rest is important.
- Inform your doctor if you have kidney issues or muscle disorders.
- You may be given additional medications like atropine.
- Follow-up tests may be needed to check your recovery and organ function.
- Notify medical staff about any new symptoms after treatment.